Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease [Phase 2]
A completed Phase 2 trial evaluated Flos Gossypii flavonoids tablet in Alzheimer's disease, assessing efficacy and safety. The trial was spo…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Single Dose Escalation Study of CM383 in Healthy Volunteers [Phase 1]
Phase 1 single-dose escalation study of CM383 in healthy volunteers is currently recruiting for testing safety and pharmacokinetics, in the …
-
CLINICAL_TRIALS withdrawal · 2024-11-07Clinical Trial Update: Voice and Swallowing Disorders in Adults With and Without Alzheimer's Disease
The clinical trial NCT06328374 evaluating voice and swallowing disorders in adults with and without Alzheimer’s disease has been withdrawn.
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Targeting zDHHC Enzymes to Counteract Alzheimer's Disease
A clinical trial is being planned to evaluate inhibitors of zDHHC enzymes as a potential approach to treating Alzheimer disease; the study s…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease [NA]
Clinical trial update reporting completion of the ADvance II study evaluating DBS-f in mild Alzheimer's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Effects of Visual Cues and Education for People Who Live Within Long Term Care Communities to Assist in Wayfinding [NA]
A completed clinical trial evaluating whether visual cues and education help residents in long-term care communities with wayfinding, with r…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease [NA]
A clinical trial is recruiting to evaluate pulsed electromagnetic field therapy for patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: The Retain Your Brain Health Study (RetainYourBrain.com) [NA]
Completed status update for the Retain Your Brain Health Study (NCT06027320) sponsored by Retain Health, Inc., investigating Alzheimer's dis…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: iTBS in MCI and Mild AD [NA]
A clinical trial is planned to evaluate intermittent theta burst stimulation (iTBS) in individuals with mild cognitive impairment and mild A…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology [Phase 2]
A Phase 2 study evaluating CY6463 in participants with Alzheimer's disease with vascular pathology has been terminated, and results were pos…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil [Phase 1]
A phase 1 study evaluating the safety and tolerability of ASP0777 in individuals with Alzheimer's disease who are taking a stable dose of do…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413) [Phase 1]
Phase 1 Cognition Platform study of MK-0000-413 in participants at risk for Alzheimer's disease, with the trial completed and results posted…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins
A clinical trial validating a fecal assay measuring amyloid peptides and tau proteins as a biomarker for Alzheimer's disease; currently recr…
-
EMA withdrawal · 2024-10-23EMA Withdrawn: Memantine LEK (memantine hydrochloride) — Pharmathen S.A.
EMA has withdrawn Memantine LEK (memantine hydrochloride) from the market. The withdrawal affects treatment for Alzheimer's disease.
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) [Phase 2]
Phase 2 clinical trial of fasudil for early Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: "Safety in Dementia": An Online Caregiver Intervention [NA]
A completed clinical trial from the University of Colorado Denver evaluating an online caregiver intervention for dementia-related safety an…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Repetitive TMS of the Posterior DMN in AD [NA]
A clinical trial evaluating repetitive transcranial magnetic stimulation targeting the posterior default mode network in Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants [Phase 1]
Phase 1 study comparing Sabirnetug IV and Sabirnetug with rHuPH20 SC in healthy participants to assess safety, tolerability, and pharmacokin…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia) [NA]
The CB3 Pilot trial evaluating a person-centered internet-based intervention for Primary Progressive Aphasia has completed and posted result…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Florbetaben PET Imaging in PPA
A completed clinical trial evaluating Florbetaben PET imaging in patients with Primary Progressive Aphasia and Alzheimer's Disease.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
The completed clinical trial evaluated florbetapir as a PET imaging agent in Primary Progressive Aphasia and related dementias, including Al…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Safety of a Strategy Combining Etanercept Administration with Repeated Contrast Ultrasound in Patients with Alzheimer's Disease [Phase 1]
A Phase 1 clinical trial evaluating the safety of combining etanercept administration with repeated contrast-enhanced ultrasound in patients…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008) [Phase 2]
Phase 2 clinical trial update reporting the efficacy and safety results of MK-1942 as an adjunct therapy in people with mild-to-moderate Alz…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Cerebellar ITBS Mode Transcranial Magnetic Stimulation for the Treatment of Alzheimer's Disease [NA]
Status update indicating that a clinical trial evaluating cerebellar ITBS mode transcranial magnetic stimulation for Alzheimer’s disease has…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: CONSTELLATIONS Living Lab: Improving the Care Transitions of Older Adults Living with Neurocognitive Disorders [NA]
CONSTELLATIONS Living Lab, sponsored by Laval University, aims to improve care transitions for older adults with neurocognitive disorders. T…